Bruno Märkl Selected Research

Complement System Proteins (Complement)

1/2022

Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruno Märkl Research Topics

Disease

34	Neoplasms (Cancer) 02/2024 - 03/2010
14	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 07/2007
10	Colonic Neoplasms (Colon Cancer) 12/2023 - 12/2008
8	Stomach Neoplasms (Stomach Cancer) 11/2023 - 03/2009
7	COVID-19 01/2023 - 01/2021
5	Neoplasm Metastasis (Metastasis) 08/2021 - 03/2010
3	Infections 04/2024 - 08/2011
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2024 - 10/2010
3	Lymphatic Metastasis 11/2023 - 09/2013
3	Adenocarcinoma 09/2021 - 04/2021
3	Carcinoma (Carcinomatosis) 12/2020 - 04/2017
3	Sarcoma (Soft Tissue Sarcoma) 09/2018 - 02/2016
3	Rectal Neoplasms (Rectal Cancer) 05/2009 - 07/2007
2	Disease Progression 04/2024 - 07/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2003
2	Lymphoma (Lymphomas) 01/2023 - 11/2019
2	Immunoglobulin G4-Related Disease 11/2019 - 01/2011
2	Breast Neoplasms (Breast Cancer) 07/2019 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 08/2018 - 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 12/2024
1	Neuroendocrine Carcinoma 02/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2022
1	Superinfection 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Cough 09/2020
1	Dyspnea (Shortness of Breath) 09/2020
1	Multiple Sclerosis 09/2020
1	Autoimmune Pancreatitis 11/2019
1	Lymphadenopathy 11/2019
1	Stomach Ulcer (Gastric Ulcer) 11/2019
1	Barrett Esophagus (Barrett's Esophagus) 01/2019
1	Ulcer 01/2019
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019
1	Acinar Cell Carcinoma 01/2019
1	Pathologic Constriction (Stenosis) 01/2019
1	Tuberous Sclerosis (Bourneville's Disease) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Hyperplasia 01/2018
1	Myopericytoma 02/2017
1	Angiomyoma (Angioleiomyoma) 02/2017

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2017
8	Keratins (Keratin)IBA 04/2021 - 07/2013
8	Methylene Blue (Methylthioninium Chloride)FDA Link 05/2016 - 07/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
3	SteroidsIBA 12/2024 - 08/2011
3	Transcription Factors (Transcription Factor)IBA 02/2024 - 01/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 11/2023
2	Hematoxylin (Haematoxylon)IBA 01/2024 - 11/2023
2	Indicators and Reagents (Reagents)IBA 11/2023 - 09/2021
2	LectinsIBA 01/2023 - 01/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 11/2019
2	Immunoglobulin G (IgG)IBA 11/2019 - 01/2011
2	Plasminogen Activator Inhibitor 1IBA 07/2019 - 01/2017
2	Peptide Hydrolases (Proteases)FDA Link 07/2019 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 09/2018 - 01/2016
2	MART-1 AntigenIBA 02/2016 - 01/2013
1	Glial Fibrillary Acidic ProteinIBA 12/2024
1	CalciumIBA 12/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 03/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 03/2023
1	Calcibiotic Root Canal SealerIBA 02/2023
1	COVID-19 VaccinesIBA 01/2023
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2022
1	Cortisone FDA Link 01/2022
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	VaccinesIBA 01/2022
1	Complement Factor D (Factor D)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	CollagenIBA 10/2021
1	tyramine-deoxysorbitolIBA 08/2021
1	Nucleic AcidsIBA 05/2021
1	Viral RNAIBA 03/2021
1	rovalpituzumab tesirineIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	delta proteinIBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Alemtuzumab (Campath)FDA Link 09/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	Member 3 Group A Nuclear Receptor Subfamily 4IBA 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019
1	Prednisolone (Predate)FDA LinkGeneric 01/2019
1	lipoarabinomannan (LAM)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018
1	Bevacizumab (Avastin)FDA Link 09/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	vandetanib (ZD6474)IBA 01/2018

Therapy/Procedure

18	Therapeutics 04/2024 - 07/2007
6	Lymph Node Excision (Lymph Node Dissection) 05/2016 - 02/2003
5	Drug Therapy (Chemotherapy) 12/2023 - 07/2010
2	Immunotherapy 01/2023 - 03/2019
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2018 - 01/2018
1	Neoadjuvant Therapy 01/2023
1	Personal Protective Equipment 03/2022
1	Radiotherapy 05/2017